Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Ko

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Annals of Surgical Oncology|February 26, 2010
Role of computed tomography in the surgical management of patients with bowel obstruction secondary to recurrent ovarian carcinomaJ Alejandro Rauh-Hain, Alexander B Olawaiye, Munro Munro, et al.
Obstetrics and Gynecology|June 22, 2011
Endometrial intraepithelial neoplasia: clinical correlates and outcomesLuwam G Semere, Emily Ko, Natasha R Johnson, et al.
Gynecologic Oncology|December 9, 2015
The use of novel technology-based weight loss interventions for obese women with endometrial hyperplasia and cancerAshley F Haggerty, Sarah Huepenbecker, David B Sarwer, et al.
Gynecologic Oncology|August 27, 2015
The prescription or proscription of exercise in endometrial cancer careXiaochen Zhang, Ashley F Haggerty, Justin C Brown, et al.
The Canadian Journal of Hospital Pharmacy|June 28, 2014
Identifying barriers to medication discharge counselling by pharmacistsSandra A N Walker, Jennifer K Lo, Sara Compani, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 31, 2016
Race-based disparities in loss of functional independence after hysterectomy for uterine cancerLorraine T Dean, Xiaochen Zhang, Nawar Latif, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2020
Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology StudyDmitriy Zamarin, Robert A Burger, Michael W Sill, et al.
Gynecologic Oncology|July 12, 2025
Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2)Sarah S Lee, Angeles Alvarez Secord, Steven Friedman, et al.
Gynecologic Oncology|February 22, 2025
Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort studyPaulina J Haight, Marilyn Sanchez, Samantha M Thomas, et al.
Gynecologic Oncology|September 25, 2023
TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomesKarley Whelan, Mairead Dillon, Kyle C Strickland, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Annals of Surgical Oncology|February 26, 2010
Role of computed tomography in the surgical management of patients with bowel obstruction secondary to recurrent ovarian carcinomaJ Alejandro Rauh-Hain, Alexander B Olawaiye, Munro Munro, et al.
Obstetrics and Gynecology|June 22, 2011
Endometrial intraepithelial neoplasia: clinical correlates and outcomesLuwam G Semere, Emily Ko, Natasha R Johnson, et al.
Gynecologic Oncology|December 9, 2015
The use of novel technology-based weight loss interventions for obese women with endometrial hyperplasia and cancerAshley F Haggerty, Sarah Huepenbecker, David B Sarwer, et al.
Gynecologic Oncology|August 27, 2015
The prescription or proscription of exercise in endometrial cancer careXiaochen Zhang, Ashley F Haggerty, Justin C Brown, et al.
The Canadian Journal of Hospital Pharmacy|June 28, 2014
Identifying barriers to medication discharge counselling by pharmacistsSandra A N Walker, Jennifer K Lo, Sara Compani, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 31, 2016
Race-based disparities in loss of functional independence after hysterectomy for uterine cancerLorraine T Dean, Xiaochen Zhang, Nawar Latif, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2020
Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology StudyDmitriy Zamarin, Robert A Burger, Michael W Sill, et al.
Gynecologic Oncology|July 12, 2025
Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2)Sarah S Lee, Angeles Alvarez Secord, Steven Friedman, et al.
Gynecologic Oncology|February 22, 2025
Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort studyPaulina J Haight, Marilyn Sanchez, Samantha M Thomas, et al.
Gynecologic Oncology|September 25, 2023
TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomesKarley Whelan, Mairead Dillon, Kyle C Strickland, et al.
Pageof 4